CJC-1295 No DAC

CJC-1295 no DAC is a synthetic growth hormone-releasing hormone analog commonly identified as Modified GRF (1-29). Vertex Labs supplies CJC-1295 no DAC as a 10 mg lyophilized powder in a sealed research vial for controlled laboratory research, analytical evaluation, and non-clinical research workflows.

Unlike the DAC-modified variant, this research material is identified by its non-DAC peptide structure, defined sequence, and associated molecular characteristics. These properties provide clear reference points for laboratory identification, batch documentation, and controlled material tracking.

Product Specifications

Research Material Identification

CJC-1295 no DAC is identified by its Modified GRF (1-29) peptide structure and absence of a Drug Affinity Complex modification. This distinction is important for differentiating the material from CJC-1295 with DAC within laboratory documentation and controlled research workflows.

Researchers should verify the vial label, fill amount, DAC status, batch number, sequence information, and corresponding analytical documentation before use. Maintaining accurate material identification and batch traceability supports consistency across individual laboratory workflows.

Sequence

Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2

Quality & Documentation

Each CJC-1295 no DAC batch released by Vertex Labs is supported by batch-level documentation and Certificate of Analysis availability following quality review. Documentation may include identity confirmation, purity assessment, active weight verification, labeling review, and other analytical information relevant to the specific research batch.

Review available batch documentation through the
Vertex Labs COA database.
Additional information regarding laboratory review procedures, documentation standards, and quality controls is available on our
Testing Standards page.

Handling & Storage

CJC-1295 no DAC should be handled using established laboratory practices and appropriate internal quality procedures. Personnel should review the product label, batch-specific documentation, container condition, and applicable storage requirements before use in a controlled laboratory environment.

Keep the vial sealed until required for laboratory preparation and store the material according to the conditions specified on the product label. Laboratories should maintain appropriate handling, documentation, and material-control procedures for their research environment.